The goal of this clinical trial is to explore the safety and effectiveness of stoma reversal combining bio-mesh placement in patients with high risk of stoma site incisional hernia (SSIH). The main questions it aims to answer are: * Whether bio-mesh placement is safe for patients with a high risk of SSIH. * Whether stoma reversal combining bio-mesh placement is a preventive strategy for patients with high risk of SSIH. * Whether stoma reversal combining bio-mesh placement will trigger other complications. Participants who are eligible and are enrolled in this study will receive stoma reversal combining bio-mesh placement surgery. After that, they will be followed up for one year to evaluate the occurrence of SSIH and other complications.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
stoma site incisional hernia
Timeframe: one-year after surgery